Clinical Trial Update: Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of Changkang Granules for diarrhea-predominant irritable bowel syndrome, with the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• Changkang Granules

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Diarrhea-predominant Irritable Boewl Syndrome | Phase 3 | Status: NOT_YET_RECRUITING